Cynosure Inc last week announced the presentation of a new study that demonstrates the clinical benefits of using a 1440 nm wavelength in laser-assisted lipolysis to disrupt fat tissue and tighten skin through tissue coagulation. The study, led by Barry DiBernardo, MD, Medical Director of New Jersey Plastic Surgery, evaluated the fat-disruption and tissue tightening that occurred in abdominal tissue treated with three separate wavelengths, including a 1440-nm laser.
"At the same power and doses, tissue treated with the 1440 nm laser disrupted a larger area of fat tissue and demonstrated greater tissue tightening effects than the other wavelengths," DiBernardo says in a press announcement released in advance of the ASLMS meeting. "The conclusion that can be drawn from this research is that, in terms of the efficiency of fat removal and collagen remodeling, wavelength and laser energy play an integral role in patient outcomes. In comparing these three unique wavelengths, the results from the 1440 nm laser demonstrated the most pronounced histological effects."
Highlights from other Smartlipo-related abstracts being presented at the ASLMS included the following:
A 15-patient study conducted by John Millard, MD, of the Millard Plastic Surgery Center in Colorado, who describes the successful use of the Smartlipo Triplex to not only improve body contour but also to highlight the three-dimensional muscular definition of areas including the arms, legs and abdomen. In addition, plastic surgeons Robert Gotkin, MD, and Alberto Goldman, MD, used the dual-wavelength Smartlipo MPX in a 20-patient study of women who underwent laser lipoabdominoplasty, a procedure to reduce the elevation of the abdominal flap. All patients tolerated the surgery well, without major complications. In comparison with the traditional and more invasive abdominoplasty procedure, the researchers concluded that the Multiplex procedure increased the contraction of skin and fat tissue, reduced the operative trauma associated with the procedure and enhanced the patients’ post-operative recovery experience.
[Source: Cynosure Inc]